Company Filing History:
Years Active: 1998-2001
Title: The Innovative Mind of Daniel Sinnett
Introduction
Daniel Sinnett, an inventor based in Boucherville, Canada, is known for his significant contributions to the fields of diagnostics and pharmacogenetics. With a remarkable portfolio of two patents, Sinnett has made strides in understanding genetic variations and their implications in cancer therapeutics and drug metabolism.
Latest Patents
Sinnett's latest patents are groundbreaking in their approach to detecting genetic polymorphisms and diagnosing cancer. The first patent focuses on the "Detection of CYP1A1, CYP3A4, CYP2D6 and NAT2 variants by PCR-allele-specific oligonucleotide (ASO) assay." This invention outlines a method for identifying genetic variations in individuals through PCR amplification of specific loci, followed by hybridization with allele-specific oligonucleotides to visualize results. This methodology is crucial for advancements in diagnostics and drug metabolism.
The second patent, pertaining to "DNA markers to detect cancer cells expressing a mutator phenotype," describes a comprehensive method for diagnosing or prognosing tumor cells exhibiting a mutator phenotype. The process entails obtaining genomic DNA samples from both tumor and tumor-free tissues, amplifying the samples, and analyzing variations in band profiles that may indicate genomic instability associated with cancer. This innovative technique promises to enhance cancer detection and treatment strategies.
Career Highlights
Daniel Sinnett has worked with notable organizations, including Signalgene Inc. and the Centre De Recherche De l'Hôpital Sainte-Justine. His work in these esteemed institutions has allowed him to collaborate with leading professionals in the field, furthering his research and innovation endeavors.
Collaborations
Throughout his career, Sinnett has had the privilege of working alongside esteemed colleagues such as Damian Labuda and Damian LaBuda. These collaborations have enriched his research, facilitating extensive exploration and development of innovative methodologies in genetics.
Conclusion
Daniel Sinnett exemplifies the spirit of innovation with his contributions to the understanding of genetic variations and their role in health and disease. His patents stand as a testament to his dedication and expertise in the field, promising advancements in diagnostics and cancer therapeutics that could benefit countless individuals.